This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sullender, W. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sullender, W. M.

Next Article 

Clinical Microbiology Reviews, January 2000, p. 1-15, Vol. 13, No. 1
0893-8512/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Respiratory Syncytial Virus Genetic and Antigenic Diversity

Wayne M. Sullender*

Department of Pediatrics, The University of Alabama at Birmingham, Birmingham, Alabama 35233

Respiratory syncytial virus (RSV) is a major cause of viral lower respiratory tract infections among infants and young children in both developing and developed countries. There are two major antigenic groups of RSV, A and B, and additional antigenic variability occurs within the groups. The most extensive antigenic and genetic diversity is found in the attachment glycoprotein, G. During individual epidemic periods, viruses of both antigenic groups may cocirculate or viruses of one group may predominate. When there are consecutive annual epidemics in which the same group predominates, the dominant viruses are genetically different from year to year. The antigenic differences that occur among these viruses may contribute to the ability of RSV to establish reinfections throughout life. The differences between the two groups have led to vaccine development strategies that should provide protection against both antigenic groups. The ability to discern intergroup and intragroup differences has increased the power of epidemiologic investigations of RSV. Future studies should expand our understanding of the molecular evolution of RSV and continue to contribute to the process of vaccine development.


* Mailing address: Department of Pediatrics, The University of Alabama at Birmingham, 1600 7th Ave. South, Suite 752, Birmingham, AL 35233. Phone: (205) 939-9590. Fax: (205) 975-6549. E-mail: pedp019{at}uabdpo.dpo.uab.edu.


Clinical Microbiology Reviews, January 2000, p. 1-15, Vol. 13, No. 1
0893-8512/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Alvarez, R., Elbashir, S., Borland, T., Toudjarska, I., Hadwiger, P., John, M., Roehl, I., Morskaya, S. S., Martinello, R., Kahn, J., Van Ranst, M., Tripp, R. A., DeVincenzo, J. P., Pandey, R., Maier, M., Nechev, L., Manoharan, M., Kotelianski, V., Meyers, R. (2009). RNA Interference-Mediated Silencing of the Respiratory Syncytial Virus Nucleocapsid Defines a Potent Antiviral Strategy. Antimicrob. Agents Chemother. 53: 3952-3962 [Abstract] [Full Text]  
  • Reiche, J., Schweiger, B. (2009). Genetic Variability of Group A Human Respiratory Syncytial Virus Strains Circulating in Germany from 1998 to 2007. J. Clin. Microbiol. 47: 1800-1810 [Abstract] [Full Text]  
  • Moore, M. L., Chi, M. H., Luongo, C., Lukacs, N. W., Polosukhin, V. V., Huckabee, M. M., Newcomb, D. C., Buchholz, U. J., Crowe, J. E. Jr., Goleniewska, K., Williams, J. V., Collins, P. L., Peebles, R. S. Jr. (2009). A Chimeric A2 Strain of Respiratory Syncytial Virus (RSV) with the Fusion Protein of RSV Strain Line 19 Exhibits Enhanced Viral Load, Mucus, and Airway Dysfunction. J. Virol. 83: 4185-4194 [Abstract] [Full Text]  
  • Song, W., Liu, G., Bosworth, C. A., Walker, J. R., Megaw, G. A., Lazrak, A., Abraham, E., Sullender, W. M., Matalon, S. (2009). Respiratory Syncytial Virus Inhibits Lung Epithelial Na+ Channels by Up-regulating Inducible Nitric-oxide Synthase. J. Biol. Chem. 284: 7294-7306 [Abstract] [Full Text]  
  • Zlateva, K. T., Vijgen, L., Dekeersmaeker, N., Naranjo, C., Van Ranst, M. (2007). Subgroup Prevalence and Genotype Circulation Patterns of Human Respiratory Syncytial Virus in Belgium during Ten Successive Epidemic Seasons. J. Clin. Microbiol. 45: 3022-3030 [Abstract] [Full Text]  
  • Deplanche, M., Lemaire, M., Mirandette, C., Bonnet, M., Schelcher, F., Meyer, G. (2007). In vivo evidence for quasispecies distributions in the bovine respiratory syncytial virus genome. J. Gen. Virol. 88: 1260-1265 [Abstract] [Full Text]  
  • Parveen, S., Sullender, W. M., Fowler, K., Lefkowitz, E. J., Kapoor, S. K., Broor, S. (2006). Genetic Variability in the G Protein Gene of Group A and B Respiratory Syncytial Viruses from India. J. Clin. Microbiol. 44: 3055-3064 [Abstract] [Full Text]  
  • Trento, A., Viegas, M., Galiano, M., Videla, C., Carballal, G., Mistchenko, A. S., Melero, J. A. (2006). Natural History of Human Respiratory Syncytial Virus Inferred from Phylogenetic Analysis of the Attachment (G) Glycoprotein with a 60-Nucleotide Duplication. J. Virol. 80: 975-984 [Abstract] [Full Text]  
  • Claassen, E. A. W., van der Kant, P. A. A., Rychnavska, Z. S., van Bleek, G. M., Easton, A. J., van der Most, R. G. (2005). Activation and Inactivation of Antiviral CD8 T Cell Responses during Murine Pneumovirus Infection. J. Immunol. 175: 6597-6604 [Abstract] [Full Text]  
  • Mejias, A., Chavez-Bueno, S., Rios, A. M., Aten, M. F., Raynor, B., Peromingo, E., Soni, P., Olsen, K. D., Kiener, P. A., Gomez, A. M., Jafri, H. S., Ramilo, O. (2005). Comparative Effects of Two Neutralizing Anti-Respiratory Syncytial Virus (RSV) Monoclonal Antibodies in the RSV Murine Model: Time versus Potency. Antimicrob. Agents Chemother. 49: 4700-4707 [Abstract] [Full Text]  
  • Galiano, M. C., Palomo, C., Videla, C. M., Arbiza, J., Melero, J. A., Carballal, G. (2005). Genetic and Antigenic Variability of Human Respiratory Syncytial Virus (Groups A and B) Isolated over Seven Consecutive Seasons in Argentina (1995 to 2001). J. Clin. Microbiol. 43: 2266-2273 [Abstract] [Full Text]  
  • Genovese, D., Dettori, S., Argentini, C., Villano, U., Chionne, P., Angelico, M., Rapicetta, M. (2005). Molecular Epidemiology of Hepatitis C Virus Genotype 4 Isolates in Egypt and Analysis of the Variability of Envelope Proteins E1 and E2 in Patients with Chronic Hepatitis. J. Clin. Microbiol. 43: 1902-1909 [Abstract] [Full Text]  
  • Alvarez, R., Harrod, K. S., Shieh, W.-J., Zaki, S., Tripp, R. A. (2004). Human Metapneumovirus Persists in BALB/c Mice despite the Presence of Neutralizing Antibodies. J. Virol. 78: 14003-14011 [Abstract] [Full Text]  
  • Ishiguro, N., Ebihara, T., Endo, R., Ma, X., Kikuta, H., Ishiko, H., Kobayashi, K. (2004). High Genetic Diversity of the Attachment (G) Protein of Human Metapneumovirus. J. Clin. Microbiol. 42: 3406-3414 [Abstract] [Full Text]  
  • Bastien, N., Liu, L., Ward, D., Taylor, T., Li, Y. (2004). Genetic Variability of the G Glycoprotein Gene of Human Metapneumovirus. J. Clin. Microbiol. 42: 3532-3537 [Abstract] [Full Text]  
  • Avendano, L. F., Palomino, M. A., Larranaga, C. (2003). Surveillance for Respiratory Syncytial Virus in Infants Hospitalized for Acute Lower Respiratory Infection in Chile (1989 to 2000). J. Clin. Microbiol. 41: 4879-4882 [Abstract] [Full Text]  
  • Rajala, M. S., Sullender, W. M., Prasad, A. K., Dar, L., Broor, S. (2003). Genetic Variability among Group A and B Respiratory Syncytial Virus Isolates from a Large Referral Hospital in New Delhi, India. J. Clin. Microbiol. 41: 2311-2316 [Abstract] [Full Text]  
  • Oomens, A. G. P., Megaw, A. G., Wertz, G. W. (2003). Infectivity of a Human Respiratory Syncytial Virus Lacking the SH, G, and F Proteins Is Efficiently Mediated by the Vesicular Stomatitis Virus G Protein. J. Virol. 77: 3785-3798 [Abstract] [Full Text]  
  • Smith, A. L., Hesketh, P., Archer, A., Shirley, M. W. (2002). Antigenic Diversity in Eimeria maxima and the Influence of Host Genetics and Immunization Schedule on Cross-Protective Immunity. Infect. Immun. 70: 2472-2479 [Abstract] [Full Text]